Injectable treatment in this practice is approached as a framework, not a menu of products. Volume, contour, proportion, and tissue behaviour are assessed together — the aim is facial balance over time, not isolated responses to individual concerns.
Where previous treatment is part of the picture, the starting point is assessment of what is already present — not automatic continuation. The treatment plan is built around current anatomy and indication.
The pathways below represent the categories used in this practice. Each is applied selectively, only where clinically indicated. Not every consultation results in treatment — the correct plan may be reassessment, correction, or no injection at this stage.
Treatment pathways — used selectively
Neuromodulators are used to soften selected dynamic lines where muscle activity is a contributing factor. Treatment targets specific muscles only — it is not applied as a blanket approach across the upper face or forehead. Dose and placement are anatomy-dependent and calibrated to preserve natural movement and expression rather than produce a uniformly static appearance.
Dermal filler is placed where volume restoration or contour refinement is anatomically indicated — plane, product viscosity, and volume are considered relative to long-term tissue behaviour, not immediate effect. Treatment is not high-volume by default; the objective is proportional restoration within the context of existing tissue and facial structure. Where filler is appropriate, limited volume is often better distributed according to overall facial balance rather than concentrated into a single focal area. Where filler is already present, it is assessed rather than automatically continued — for its location, distribution, and anatomical appropriateness. Correction, including dissolution, is part of the treatment planning process, not a separate service.
Skin-quality injectables address hydration, tissue resilience, and surface condition where these form part of a defined treatment goal. This category is distinct from biostimulatory treatment in mechanism and depth — the focus is on extracellular support and skin quality rather than structural collagen stimulation. Relevant within a broader plan; not applied as a standalone cosmetic routine.
Existing filler can be assessed with ultrasound to evaluate its precise location, distribution, and anatomical relationship to surrounding structures. This is particularly relevant where complex or long-standing filler histories, migration concerns, or vascular proximity are part of the clinical picture.
Where clinically indicated, dissolution can be performed under ultrasound guidance for more targeted and controlled correction — improving precision when the exact location of existing product is uncertain or when conventional assessment alone is insufficient. This applies to previously treated areas requiring reassessment and to cases where anatomical concern warrants a more measured approach to correction.
Placement is conservative, controlled, and based on anatomical landmarks. Product choice, plane, depth, and volume are considered in relation to long-term tissue behaviour, facial proportion, and the broader treatment plan. The aim is not simply to place product, but to integrate treatment in a way that remains coherent over time. The objective is coherence, not immediate visible change alone.